Program Schedule

548
Implementing New Diagnostic Tools for Antimicrobial Stewardship

Session: Symposium: Antimicrobial Stewardship—The Latest Trends and Opportunities
Thursday, October 9, 2014: 5:15 PM
Room: The Pennsylvania Convention Center: 103-ABC
Stephan Harbarth, MD, MS, Infection Control Program, University of Geneva Hospitals and Medical School, Geneve, Switzerland

Stephan J. Harbarth, MD, MS, is a Senior Research Associate, Hospital Epidemiologist and Attending Physician in Infectious Diseases at Geneva University Hospitals (Switzerland), where he directs the Antibiotic Stewardship Team. He received his Medical Doctorate from the University of Munich (Germany), completed an internal medicine residency at the University of Munich Clinics and an infectious diseases fellowship at the University of Geneva Hospitals, and obtained a Masters in Epidemiology (as a Harvard University Scholar) from the Harvard School of Public Health in Boston. In 2003, Dr Harbarth was the recipient of the Young Investigator Award by the American Society of Microbiology for research excellence and scientific promise in infectious diseases. In 2006, he received the ESCMID Young Investigator Award of the European Society of Microbiology and Infectious Diseases to recognize outstanding research in infectious disease epidemiology.
His research interest focuses on the epidemiology and prevention of antibiotic-resistant, healthcare-associated infections and has been supported by the Swiss National Research Foundation and the European Community. In particular, his studies on the impact and control of nosocomial MRSA transmission have increased our understanding of the epidemiology of MRSA and improved our ability to combat this microorganism. Other important contributions to the field of antibiotic resistance, which had an impact on policy making, are his research on the adverse effects of prolonged antibiotic prophylaxis after surgery and on the ecologic bias associated with group-level data analyses of antibiotic-use-versus-resistance relationships as well as several well-conducted intervention studies. Complementary research interests include the molecular epidemiology of emerging pathogens such as community-acquired MRSA, the pharmaco-epidemiology of antibiotic use (including international analyses of macro-level determinants of antibiotic overuse), and improved and rapid diagnosis of severe infections in critically ill patients.



<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek